What Researchers Did
This review article explored various existing and future drug therapies for managing osteoporosis.
What They Found
The authors discussed treatments aimed at reducing bone resorption, such as calcium, vitamin D metabolites, estrogens, calcitonin, diphosphonates, and ipriflavone. They also covered therapies promoting bone formation, including fluorides, anabolic androgens, and PTH. Future approaches like anti-interleukin 1 and 6, and growth factors were also considered.
What This Means for Canadian Patients
For Canadian patients with osteoporosis, this review highlights a range of drug-based treatment options available to physicians, focusing on reducing bone loss or promoting bone formation. While hyperbaric oxygen therapy (HBOT) is listed in the study's medical subject headings, the abstract itself does not detail its role or benefits in osteoporosis management.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
This review article, published in 1994, reflects an understanding of osteoporosis therapy that is now outdated and does not provide specific details on hyperbaric oxygen therapy.